Open Access

Food intake regulating-neuropeptides are expressed and regulated through pregnancy and following food restriction in rat placenta

  • Jorge E Caminos1, 2, 3,
  • Susana B Bravo1,
  • C Ruth González1,
  • Maria F Garcés1, 2,
  • Libia A Cepeda2,
  • Adriana C González2,
  • Fernando Cordido3,
  • Miguel López1, 4 and
  • Carlos Diéguez1, 4Email author
Reproductive Biology and Endocrinology20086:14

https://doi.org/10.1186/1477-7827-6-14

Received: 04 December 2007

Accepted: 02 April 2008

Published: 02 April 2008

Abstract

Background

Neuropeptide Y (NPY), agouti related peptide (AgRP), cocaine and amphetamine-regulated transcript (CART) and melanocortins, the products of the proopiomelanocortin (POMC), are hypothalamic peptides involved in feeding regulation and energy homeostasis. Recent evidence has demonstrated their expression in rat and human placenta.

Methods

In the current study, we have investigated the expression of those neuropeptides in the rat placenta by real-time PCR using a model of maternal food restriction.

Results

Our results showed that placental-derived neuropeptides were regulated through pregnancy and following food restriction.

Conclusion

These data could indicate that placental-derived neuropeptides represent a local regulatory circuit that may fine-tune control of energy balance during pregnancy.

Background

The regulation of body weight is carried out by a complex inter-organ circuit connecting the periphery and the brain, where neurons in the hypothalamus and brainstem exert potent effects on feeding and energy expenditure [1, 2]. Short-acting and long-term body-weight regulating signals mainly originate from: 1) the adipose tissue, such as leptin, and interleukin 6 (IL-6); 2) the pancreas, like insulin or amylin; 3) the gastrointestinal tract such as ghrelin, glucagon-like peptide-1 (GLP-1), peptide YY (PYY), cholecystokinin (CCK) and neuropeptide W (NPW); 4) the sensory vagus nerve [2]. These neural and humoral signals interact at the brain level with widely-located target receptors related with the nutritional state, metabolism and reproduction [2, 3].

Hypothalamic neuropeptide expression and regulation are stimulated by inputs from peripherally-derived hormonal and nutrient-related signals essential for the central control of energy homeostasis in mammals. Neuropeptide Y (NPY), melanocortins (POMC-derived products), agouti related peptide (AgRP), cocaine and amphetamine regulated transcript (CART), melanin concentrating hormone (MCH) and orexins, have been characterized in both rodent models and humans, by having either direct or indirect effects in the feedback loop of body weight regulation and reproduction [4, 5].

NPY and AgRP are two anabolic neuropeptides that promote weight gain by reducing energy expenditure and stimulating food intake. They are coexpressed in arcuate nucleus (ARC) neurons, which are inhibited by insulin and leptin [4, 6]. In contrast, CART and POMC, also coexpressed in the ARC neurons, are stimulated by inputs from insulin and leptin and these catabolic neuronal pathways act to reduce feeding and increase energy expenditure [4, 6].

Besides their role in food intake control, hypothalamic neuropeptides have also been identified in female reproductive tissues, such as the placenta and appear to have an important role in the physiology of pregnancy [714]. It is interesting to note that the placenta may play an important role not only in reproduction but is also an important site for translating inputs from diverse hormonal signals that powerfully influence energy balance within the fetus [15, 16]. The aim of this study was to evaluate the ontogenic mRNA expression pattern of NPY, AgRP, POMC, and CART throughout pregnancy in the rat placenta. In addition, we have determined the effects of chronic food restriction on their expression levels.

Methods

Animals

Pregnant female rats of the Sprague Dawley strain aged between 10–12 weeks (bred in the Animalario General USC; Santiago de Compostela, Spain), were housed in a temperature-regulated room with a 12 h light/12 h dark cycle, with tap water and standard rat chow ad libitum or a food-restricted diet (see below). At the end of the study period, animals were sacrificed, hypothalami and placentas were removed from each mother, and snap-frozen in liquid nitrogen for RNA extraction and real time semi-quantitative RT-PCR. All experiments and procedures in this study were carried out according to a protocol approved by the Ethics Committee of the University of Santiago de Compostela in accordance with the European Union normative for the care and use of experimental animals.

Maternal chronic food-restriction

A maternal chronic food-restriction model was used throughout pregnancy to study the effect of long-term undernutrition on placental neuropeptide mRNA expression as previously described [17]. Briefly, virgin rats were mated on the day of proestrus and the day on which spermatozoa were present in vaginal smear, was designated gestational day 1. The pregnant rats were divided into two dietary groups: pregnant rats fed ad libitum and food-restricted group of pregnant rats fed 30% of ad libitum intake. Food-restricted animals were fed every day at 18:00 hours. Rats were sacrificed at gestational days 12, 16 and 21. We used 9 hypothalami and placentas per experimental group, extracted from 9 different mothers. All the samples were analyzed individually and samples were not pooled.

RNA Isolation and real-time RT-PCR

Placental neuropeptide gene expression was analyzed by reverse transcription polymerase chain reaction (RT-PCR) as previously validated [1820]. Total RNA was isolated using Trizol according to the manufacturer's protocol (Invitrogen, CA). First-strand cDNA was synthesized from 2 μg of total RNA by random primer reverse transcription. A negative control without MMLV reverse transcriptase was used to ensure specificity of the PCR amplification. The resulting cDNA was subjected to PCR amplification using sense and antisense primers specific for rat AgRP, CART, NPY and POMC mRNAs (Table 1). Primer pairs were designed overlapping on different exons to prevent amplification from any contaminated genomic DNA (data not shown). To verify the identity of amplified cDNAs, PCR products were electrophoresed on a 1.5% agarose gel, which yielded DNA fragments of the expected length for all mRNAs and were confirmed by sequencing (data not shown). Rat hypoxanthine guanine phosphoribosyl transferase (HPRT) was used as a control housekeeping gene. PCR was performed by real-time in LightCycler real-time PCR machine 2 (Roche Diagnostics, Germany) and the software version 3.5, according to the method described elsewhere [1921]. Briefly, the PCR protocol consisted of initial denaturation at 96°C for 5 min, followed by 35 cycles of denaturation (96°C for 2 s), annealing (62°C for 15 s) and elongation (72°C for 15 s). This was followed by melting curve analysis consisting of 1 cycle at 95°C for 30 s, 60°C for 15 s and a temperature rise to 85°C at a slope of 0.2°C/s with continuous measurement of fluorescence. The primers specify was also assured by the melting curve of each gene. All samples were standardized against HPRT by using the 2ΔΔct method [19, 22].
Table 1

Primers used for real-time RT-PCR

mRNA

Primer Sequence (5'-3')

Product size (bp)

Accession Number

NPY

Forward

cgctctgcgacactacatca

157

NM_012614

 

Reverse

tttcatttcccatcaccaca

  

AgRP

Forward

tgtgggccctttattagacc

156

XM_574228

 

Reverse

ccatatggacccccaatgt

  

POMC

Forward

tccatagacgtgtggagctg

174

NM_139326

 

Reverse

gacgtacttccggggatttt

  

CART

Forward

gccctggacatctactctgc

201

NM_017110

 

Reverse

cactgcgcactgctctcc

  

HPRT

Forward

cagtcccagcgtcgtgatta

137

NM_012583

 

Reverse

agcaagtctttcagtcctgtc

  

Statistical analysis

Statistical analyzes were performed using GraphPad Instat (version 3.05). All group values were expressed as mean ± SEM. Differences between groups were analyzed by using one-way analysis of variance (ANOVA) or Student's t-test. P < 0.05 was considered significant.

Results

NPY mRNA expression is down-regulated by food restriction in the rat placenta

Firstly, we studied the hypothalamic mRNA levels of NPY during pregnancy and after food restriction. Our data showed that the transcriptional expression of NPY is increased at the latest pregnancy stage (21 days; P < 0.001) with food restriction inducing a further increase at both 16 and 21 days of pregnancy (P < 0.001 and P < 0.05, respectively) (Figure 1A). Next, we evaluated the transcriptional expression of NPY in rat placenta; our results showed that placental mRNA levels of NPY were significantly higher during the initial period of gestation studied (12 days), and decreased significantly (P < 0.001) with gestational age (Figure 1B). We also studied the effect of food restriction on placental mRNA expression of NPY and these data showed that the expression profile of NPY was decreased by food restriction only at day 12 (P < 0.01), and remain unchanged between 16 to 21 days, compared to the ad libitum group (Figure 1B).
Figure 1

NPY expression in hypothalamus and placenta of ad libitum fed and food-restricted rats. Relative NPY mRNA levels in (A) hypothalamus and (B) placenta from ad libitum fed or food-restricted female rats at different pregnancy stages (12, 16 and 21 days). Relative mRNA levels were normalized to ad libitum fed (control) as 1. **: P < 0.01 vs. ad libitum 12d; ***: P < 0.001 vs. ad libitum 12d; ###: P < 0.001 vs. ad libitum 16d; !: P < 0.05 ad libitum 21d vs. food-restricted 21d.

AgRP mRNA expression is up-regulated by food restriction in the rat placenta

Throughout pregnancy, hypothalamic mRNA expression levels of AgRP were decreased (P < 0.01) at 16 and 21 days of gestation compared to 12 days and these levels were increased by food restriction (P < 0.05 and P < 0.01) at all days of gestation studied compared to the ad libitum (Figure 2A). In rat placenta, throughout the same experimental period, the expression mRNA profile of AgRP was opposite to NPY (Figure 2B). Placental AgRP expression remained unchanged between 12 and 16 days of gestation reaching the highest levels at the end of the gestation period (P < 0.001)(Figure 2B). Food restriction induced a significant and progressive increase (P < 0.05) in placenta AgRP mRNA expression at all studied time points.
Figure 2

AgRP expression in hypothalamus and placenta of ad libitum fed and food-restricted rats. Relative AgRP mRNA levels in (A) hypothalamus and (B) placenta from ad libitum fed or food-restricted female rats at different pregnancy stages (12, 16 and 21 days). Relative mRNA levels were normalized to ad libitum fed (control) as 1. *: P < 0.05 vs.ad libitum 12d; **: P < 0.01 vs. ad libitum 12d; ***: P < 0.001 vs. ad libitum 12d; #: P < 0.05 vs. ad libitum 16d; ###: P < 0.001 vs. ad libitum 16d; !: P < 0.05 ad libitum 21d vs. food-restricted 21d.

POMC mRNA expression shows a biphasic response to food restriction during pregnancy in rat placenta

Hypothalamic POMC mRNA expression was increased during pregnancy (P < 0.05) and decreased by food restriction (P < 0.01) at 12, 16 and 21 days of gestation (Figure 3A). Placental POMC mRNA expression showed a significantly (P < 0.001) increasing trend of expression from 12 to 21 days of gestation in rats fed ad libitum (Figure 3B). Placental POMC expression was significantly (P < 0.01) lower in fed ad libitum rats than in food-restricted group at 12 days. Conversely, significantly (P < 0.01) lower levels of POMC expression were detected in the food-restricted group at compared to fed ad libitum experimental group from 16 to 21 days of gestation.
Figure 3

POMC expression in hypothalamus and placenta of ad libitum fed and food-restricted rats. Relative POMC mRNA levels in (A) hypothalamus and (B) placenta from ad libitum fed or food-restricted female rats at different pregnancy stages (12, 16 and 21 days). Relative mRNA levels were normalized to ad libitum fed (control) as 1. *: P < 0.05 vs. ad libitum 12d; **: P < 0.01 vs. ad libitum 12d; ***: P < 0.001 vs. ad libitum 12d; ##: P < 0.01 vs. ad libitum 16d; ###: P < 0.001 vs. ad libitum 16d; !!: P < 0.01 ad libitum 21d vs. food-restricted 21d.

CART mRNA expression is down-regulated by food restriction in rat placenta

Hypothalamic CART mRNA expression did not show any change during the different stages of pregnancy and was decreased by food restriction (P < 0.01) at 21 days of gestation (Figure 4A). Placental CART mRNA expression did not change significantly from 12 to 16 days, showing the highest levels (P < 0.001) at 21 days of gestational age. In addition, CART mRNA expression remained unchanged throughout pregnancy from 12 to 16 days of pregnancy in food-restricted rats. Conversely, at 21 days of gestational age mRNA levels of CART were significantly lower in food-restricted rats than in fed ad libitum rats (P < 0.01) (Figure 4B).
Figure 4

CART expression in hypothalamus and placenta of ad libitum fed and food-restricted rats. Relative CART mRNA levels in (A) hypothalamus and (B) placenta from ad libitum fed or food-restricted female rats at different pregnancy stages (12, 16 and 21 days). Relative mRNA levels were normalized to ad libitum fed (control) as 1. ***: P < 0.001 vs. ad libitum 12d; ###: P < 0.001 vs. ad libitum 16d; !!: P < 0.01 ad libitum 21d vs. food-restricted 21d.

Discussion

Although the expression of feeding neuropeptides in placenta is well established, little is known about the regulation of their expression during pregnancy and by nutritional status. In this study, we investigated the placental mRNA expression levels of NPY, AgRP, CART and POMC throughout pregnancy (from day 12 to day 21) in fed and food-restricted rats.

Fetal development is critically determined by the availability and flux of nutrients and oxygen across the placenta during pregnancy. The placenta tissue is an active endocrine organ involved in the control of not only metabolism and energy balance, but also of other relevant body functions including reproduction [23, 24]. Previous studies have demonstrated the placental expression of hormones, such as ghrelin and leptin [2527], as well as neuropeptides such as NPY, AgRP, CART and POMC [711] are involved in the regulation of energy homeostasis. However, despite these data, both the physiogical relevance and the regulation of these molecules in placental tissues remain unclear.

In the hypothalamus, food restriction induces opposite and compensatory changes in neuropeptide expression. Thus, orexigenic neuropeptides such as AgRP and NPY are up-regulated by decreased food availability whilst anorexigenic neuropeptides such as CART and POMC are downregulated under the same conditions. Interestingly, AgRP, CART and POMC follow the same expression pattern in placental tissues but NPY is down-regulated in food-restricted rats. The reason for this discrepancy is unclear, but it could be related to an altered hormonal milieu after food restriction. In this sense, recent data from our group demonstrates that pregnancy hormones, such as prolactin, play a major role on hypothalamic NPY expression [28]. Whether this interaction is present in placental tissues will merit further investigation. In addition, these data support the fact that contrary to the pattern in the ARC, AgRP and NPY are probably coexpressed by different cell populations in placental tissue and may be modulated by different signals.

Whatever the case, the discrepancies in NPY expression pattern suggest that an anabolic role for placental NPY in states of increased energy demand is not clear and this possibility merits further investigation. The data from AgRP, CART and POMC suggest that their expression may be under the same, or at least, a similar transcriptional control to that in the hypothalamus. Whether placental neuropeptide protein levels correlate with mRNA expression, as in the hypothalamus, will also merit further investigation.

Conclusion

In summary, we demonstrate that central signals involved in energy homeostasis in the hypothalamus are also expressed and modulated by nutritional status in the rat placenta. These neuropeptides display a specific ontogenic expression pattern which change over the entire gestational range. They are also affected by chronic food restriction. Altogether, these data suggest that neuropeptides could play a role in the homeostatic response to energy availability in rat placenta.

Declarations

Acknowledgements

We are very grateful to Dr. Chris Lelliott (AstraZeneca R&D; Mölndal, Sweden) for his comments and criticisms. This work has been supported by grants from Xunta de Galicia (ML: GRC2006/66), Fondo Investigationes Sanitarias (ML: PI061700), Ministerio de Educacion y Ciencia (CD: BFU2005), Mútua Madrileña (CD and ML) and European Union (CD: LSHM-CT-2003-503041).

Authors’ Affiliations

(1)
Department of Physiology, School of Medicine, University of Santiago de Compostela
(2)
Department of Physiology and Genetic Institute, Faculty of Medicine, National University of Colombia
(3)
Endocrine Department, Hospital Juan Canalejo
(4)
CIBER of Obesity and Nutrition, Instituto Salud Carlos III, Santiago de Compostela

References

  1. Schwartz MW, Woods SC, Seeley RJ, Barsh GS, Baskin DG, Leibel RL: Is the energy homeostasis system inherently biased toward weight gain?. Diabetes. 2003, 52: 232-238. 10.2337/diabetes.52.2.232.View ArticlePubMedGoogle Scholar
  2. Sandoval D, Cota D, Seeley RJ: The Integrative Role of CNS Fuel-Sensing Mechanisms in Energy Balance and Glucose Regulation. Annu Rev Physiol. 2008, 70: 513-535. 10.1146/annurev.physiol.70.120806.095256.View ArticlePubMedGoogle Scholar
  3. Lopez M, Tovar S, Vazquez MJ, Williams LM, Dieguez C: Peripheral tissue-brain interactions in the regulation of food intake. Proc Nutr Soc. 2007, 66: 131-155. 10.1017/S0029665107005368.View ArticlePubMedGoogle Scholar
  4. Hillebrand JJ, de Wied D, Adan RA: Neuropeptides, food intake and body weight regulation: a hypothalamic focus. Peptides. 2002, 23: 2283-2306. 10.1016/S0196-9781(02)00269-3.View ArticlePubMedGoogle Scholar
  5. Schwartz MW, Woods SC, Porte D, Seeley RJ, Baskin DG: Central nervous system control of food intake. Nature. 2000, 404: 661-671.PubMedGoogle Scholar
  6. Leibowitz SF, Wortley KE: Hypothalamic control of energy balance: different peptides, different functions. Peptides. 2004, 25: 473-504. 10.1016/j.peptides.2004.02.006.View ArticlePubMedGoogle Scholar
  7. Beloosesky R, Gayle DA, Amidi F, Ahanya SN, Desai M, Ross MG: Ontogenic expression of putative feeding peptides in the rat fetal brain and placenta. Nutr Neurosci. 2006, 9: 33-40. 10.1080/10284150600630676.View ArticlePubMedGoogle Scholar
  8. Grigorakis SI, Anastasiou E, Dai K, Souvatzoglou A, Alevizaki M: Three mRNA transcripts of the proopiomelanocortin gene in human placenta at term. Eur J Endocrinol. 2000, 142: 533-536. 10.1530/eje.0.1420533.View ArticlePubMedGoogle Scholar
  9. Chen CL, Chang CC, Krieger DT, Bardin CW: Expression and regulation of proopiomelanocortin-like gene in the ovary and placenta: comparison with the testis. Endocrinology. 1986, 118: 2382-2389.View ArticlePubMedGoogle Scholar
  10. Dotsch J, Nusken KD, Knerr I, Kirschbaum M, Repp R, Rascher W: Leptin and neuropeptide Y gene expression in human placenta: ontogeny and evidence for similarities to hypothalamic regulation. J Clin Endocrinol Metab. 1999, 84: 2755-2758. 10.1210/jc.84.8.2755.View ArticlePubMedGoogle Scholar
  11. Singh G, Davenport AP: Neuropeptide B and W: neurotransmitters in an emerging G-protein-coupled receptor system. Br J Pharmacol. 2006, 148: 1033-1041. 10.1038/sj.bjp.0706825.PubMed CentralView ArticlePubMedGoogle Scholar
  12. Robidoux J, Simoneau L, St Pierre S, Masse A, Lafond J: Characterization of neuropeptide Y-mediated corticotropin-releasing factor synthesis and release from human placental trophoblasts. Endocrinology. 2000, 141: 2795-2804. 10.1210/en.141.8.2795.PubMedGoogle Scholar
  13. Robidoux J, Simoneau L, St Pierre S, Ech-Chadli H, Lafond J: Human syncytiotrophoblast NPY receptors are located on BBM and activate PLC-to-PKC axis. Am J Physiol. 1998, 274: E502-E509.PubMedGoogle Scholar
  14. Graf AH, Hutter W, Hacker GW, Steiner H, Anderson V, Staudach A, Dietze O: Localization and distribution of vasoactive neuropeptides in the human placenta. Placenta. 1996, 17: 413-421. 10.1016/S0143-4004(96)90023-5.View ArticlePubMedGoogle Scholar
  15. Garcia MD, Casanueva FF, Dieguez C, Senaris RM: Gestational profile of leptin messenger ribonucleic acid (mRNA) content in the placenta and adipose tissue in the rat, and regulation of the mRNA levels of the leptin receptor subtypes in the hypothalamus during pregnancy and lactation. Biol Reprod. 2000, 62: 698-703. 10.1095/biolreprod62.3.698.View ArticlePubMedGoogle Scholar
  16. Masuzaki H, Ogawa Y, Sagawa N, Hosoda K, Matsumoto T, Mise H, Nishimura H, Yoshimasa Y, Tanaka I, Mori T, Nakao K: Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med. 1997, 3: 1029-1033. 10.1038/nm0997-1029.View ArticlePubMedGoogle Scholar
  17. Gualillo O, Caminos JE, Nogueiras R, Seoane LM, Arvat E, Ghigo E, Casanueva FF, Dieguez C: Effect of food restriction on ghrelin in normal-cycling female rats and in pregnancy. Obes Res. 2002, 10: 682-687.View ArticlePubMedGoogle Scholar
  18. Nogueiras R, Barreiro ML, Caminos JE, Gaytan F, Suominen JS, Navarro VM, Casanueva FF, Aguilar E, Toppari J, Dieguez C, Tena-Sempere M: Novel expression of resistin in rat testis: functional role and regulation by nutritional status and hormonal factors. J Cell Sci. 2004, 117: 3247-3257. 10.1242/jcs.01196.View ArticlePubMedGoogle Scholar
  19. Caminos JE, Bravo SB, Garcia-Rendueles ME, Ruth GC, Garces MF, Cepeda LA, Lage R, Suarez MA, Lopez M, Dieguez C: Expression of neuropeptide W in rat stomach mucosa: Regulation by nutritional status, glucocorticoids and thyroid hormones. Regul Pept. 2007Google Scholar
  20. Lage R, Dieguez C, Lopez M: Caffeine treatment regulates neuropeptide S system expression in the rat brain. Neurosci Lett. 2006, 410: 47-51. 10.1016/j.neulet.2006.09.064.View ArticlePubMedGoogle Scholar
  21. Heid CA, Stevens J, Livak KJ, Williams PM: Real time quantitative PCR. Genome Res. 1996, 6: 986-994. 10.1101/gr.6.10.986.View ArticlePubMedGoogle Scholar
  22. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001, 25: 402-408. 10.1006/meth.2001.1262.View ArticlePubMedGoogle Scholar
  23. Myatt L: Placental adaptive responses and fetal programming. J Physiol. 2006, 572: 25-30.PubMed CentralView ArticlePubMedGoogle Scholar
  24. Jansson T, Powell TL: Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches. Clin Sci (Lond). 2007, 113: 1-13.View ArticleGoogle Scholar
  25. Gualillo O, Caminos J, Blanco M, Garcia-Caballero T, Kojima M, Kangawa K, Dieguez C, Casanueva F: Ghrelin, a novel placental-derived hormone. Endocrinology. 2001, 142: 788-794. 10.1210/en.142.2.788.PubMedGoogle Scholar
  26. Xiao Q, Han X, Arany E, Hill D, Challis JR, McDonald TJ: Human placenta and fetal membranes contain peptide YY1-36 and peptide YY3-36. J Endocrinol. 1998, 156: 485-492. 10.1677/joe.0.1560485.View ArticlePubMedGoogle Scholar
  27. Hoggard N, Hunter L, Duncan JS, Williams LM, Trayhurn P, Mercer JG: Leptin and leptin receptor mRNA and protein expression in the murine fetus and placenta. Proc Natl Acad Sci U S A. 1997, 94: 11073-11078. 10.1073/pnas.94.20.11073.PubMed CentralView ArticlePubMedGoogle Scholar
  28. Garcia MC, Lopez M, Gualillo O, Seoane LM, Dieguez C, Senaris RM: Hypothalamic levels of NPY, MCH, and prepro-orexin mRNA during pregnancy and lactation in the rat: role of prolactin. FASEB J. 2003, 17: 1392-1400. 10.1096/fj.02-0933com.View ArticlePubMedGoogle Scholar

Copyright

© Caminos et al; licensee BioMed Central Ltd. 2008

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement